Glenmark discovers new drug molecule; clinical trials by 2011

31 Aug 2010 Evaluate

Glenmark Pharmaceuticals has discovered a new drug molecule, which could be used for treating pain and respiratory disorders. The new drug molecule, codenamed ‘GRC 17536’, has completed pre-clinical trials (animal tests) and will move into clinical trials (tests on humans) in the first quarter of 2011.

GRC 17536 is another potential first-in-class globally and the results shown by the molecule in animal studies is encouraging. It has proven highly efficacious in treating inflammatory and neuropathic pain in animal models, compared to gold standard drugs. Glenmark has already filed multiple patent applications for these molecules. The company’s Novel Chemical Entity (NCE) programme is targeting pain and respiratory disorders.

crackcrack

Glenmark Pharma Share Price

1622.40 -13.65 (-0.83%)
06-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1846.95
Dr. Reddys Lab 1350.65
Cipla 1490.55
Lupin 2357.75
Zydus Lifesciences 961.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.